Home Journal of Army Medical University Article
PDF (3.8 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Abstract
Keywords
References
Show full outline
Hide outline
Publishing Language: Chinese

Effects of running on medial prefrontal cortex and microglia in APP/PS1 mice

Yijing GUO, Lin JIANG, Shanshan ZHANG, Lin ZHU, Chunni ZHOU, Lei ZHANG, Qian XIAO, Qi HE, Hao YANG, Jing LI, Yuhui DENG, Fenglei CHAO(), Yong TANG()
Department of Histology and Embryology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China
Show Author Information

Abstract

Objective

To investigate the effects of running on the volume change of medial prefrontal cortex (mPFC), as well as amyloid beta protein (Aβ) and microglia in mPFC in mouse model of Alzheimer's disease (AD).

Methods

Male APP/PS1 transgenic AD mice aged 10 months were randomly divided into AD running group (AD Run, given active running intervention for 4 months) and AD control group (AD Ctrl), while non-transgenic mice at the same age were set as normal control group (Ctrl). The mice from the AD Ctrl and Ctrl groups received no treatment. Morris water maze test was used to evaluate the abilities of spatial learning and memory of mice, and Y maze test was adopted to assess the working memory and reference memory in the mice. The volume of mPFC and the total number of microglia (IBA1+ cells) in the mPFC were quantified with stereological methods. The number of activated microglia (CD68+/IBA1+ cells) in the mPFC, cell body area, and process number of microglia, number and area of Aβ plaques, and area of Aβ plaques in IBA1+ microglia were quantitatively measured by immunofluorescence multiple labeling and laser confocal microscopy, and the ratio of area of Aβ plaques in IBA1+ microglia to the total area of Aβ plaques was calculated.

Results

The AD Run group and Ctrl group performed better than the AD Ctrl group in Morris water maze and Y maze tests. The volume of mPFC was significantly less in the AD Ctrl group than the Ctrl group (P<0.05), while that of the AD Run group was obviously larger than that of the AD Ctrl (P<0.01). The AD Ctrl group had greatly larger numbers of IBA1+ cells and CD68+/IBA1+ cells in the mPFC than the Ctrl group (P<0.05), whereas the AD Run group had much larger numbers of those cells than the AD Ctrl group (P<0.05). The total and average area of Aβ plaques in the mPFC was greatly diminished in the AD Run group than the AD Ctrl group (P<0.05). In addition, the AD Run group also presented larger numbers of IBA1+ cells and CD68+/IBA1+ cells around Aβ, larger average body area of single microglia and CD68+/IBA1+ cells, and elevated area of Aβ plaques in IBA1+ cells, along with its ratio to the total area of Aβ plaques in mPFC improved (P<0.05).

Conclusion

Running exercise increases the number of CD68+ microglia in the mPFC, reduces the Aβ plaques, delays the atrophy of mPFC, and thus improves the spatial learning and memory abilities as well as working memory and reference memory in APP/PS1 transgenic AD mice.

Keywords

Alzheimer's diseaserunningmedial prefrontal cortexmicrogliaCD68Aβ
CLC number: R165;R322.81;R745.7 Document code: A

References

[1]
2021 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2021, 17(3): 327-406. DOI: 10.1002/alz.12328.
Crossref Google Scholar
[2]
NORTON S, MATTHEWS F E, BARNES D E, et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data[J]. Lancet Neurol, 2014, 13(8): 788-794. DOI: 10.1016/S1474-4422(14)70136-X.
Crossref Google Scholar
[3]
MÜLLER S, PREISCHE O, SOHRABI H R, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease[J]. Alzheimers Dement, 2018, 14(11): 1427-1437. DOI: 10.1016/j.jalz.2018.06.3059.
Crossref Google Scholar
[4]
ZHAO N, YAN Q W, XIA J, et al. Treadmill exercise attenuates aβ-induced mitochondrial dysfunction and enhances mitophagy activity in APP/PS1 transgenic mice[J]. Neurochem Res, 2020, 45(5): 1202-1214. DOI: 10.1007/s11064-020-03003-4.
Crossref Google Scholar
[5]
TAPIA-ROJAS C, ARANGUIZ F, VARELA-NALLAR L, et al. Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer's disease[J]. Brain Pathol, 2016, 26(1): 62-74. DOI: 10.1111/bpa.12255.
Crossref Google Scholar
[6]
HOFFMANN K, SOBOL N A, FREDERIKSEN K S, et al. Moderate-to-high intensity physical exercise in patients with Alzheimer's disease: a randomized controlled trial[J]. J Alzheimers Dis, 2016, 50(2): 443-453. DOI: 10.3233/JAD-150817.
Crossref Google Scholar
[7]
HOLTHOFF V A, MARSCHNER K, SCHARF M, et al. Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study[J]. PLoS One, 2015, 10(4): e0121478. DOI: 10.1371/journal.pone.0121478.
Crossref Google Scholar
[8]
BRAWEK B, SCHWENDELE B, RIESTER K, et al. Impairment of in vivo calcium signaling in amyloid plaque-associated microglia[J]. Acta Neuropathol, 2014, 127(4): 495-505. DOI: 10.1007/s00401-013-1242-2.
Crossref Google Scholar
[9]
NEWCOMBE E A, CAMATS-PERNA J, SILVA M L, et al. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease[J]. J Neuroinflamm, 2018, 15(1): 276. DOI: 10.1186/s12974-018-1313-3.
Crossref Google Scholar
[10]
SIETTE J, WESTBROOK R F, COTMAN C, et al. Age-specific effects of voluntary exercise on memory and the older brain[J]. Biol Psychiatry, 2013, 73(5): 435-442. DOI: 10.1016/j.biopsych.2012.05.034.
Crossref Google Scholar
[11]
XU Z Q, ZHANG L Q, WANG Q, et al. Aerobic exercise combined with antioxidative treatment does not counteract moderate- or mid-stage alzheimer-like pathophysiology of APP/PS1 mice[J]. CNS Neurosci Ther, 2013, 19(10): 795-803. DOI: 10.1111/cns.12139.
Crossref Google Scholar
[12]
MAILLET D, RAJAH M N. Association between prefrontal activity and volume change in prefrontal and medial temporal lobes in aging and dementia: a review[J]. Ageing Res Rev, 2013, 12(2): 479-489. DOI: 10.1016/j.arr.2012.11.001.
Crossref Google Scholar
[13]
SALAT D H, KAYE J A, JANOWSKY J S. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease[J]. Arch Neurol, 2001, 58(9): 1403-1408. DOI: 10.1001/archneur.58.9.1403.
Crossref Google Scholar
[14]
ANTZOULATOS E G, MILLER E K. Differences between neural activity in prefrontal cortex and striatum during learning of novel abstract categories[J]. Neuron, 2011, 71(2): 243-249. DOI: 10.1016/j.neuron.2011.05.040.
Crossref Google Scholar
[15]
GAGNEPAIN P, VALLÉE T, HEIDEN S, et al. Collective memory shapes the organization of individual memories in the medial prefrontal cortex[J]. Nat Hum Behav, 2020, 4(2): 189-200. DOI: 10.1038/s41562-019-0779-z.
Crossref Google Scholar
[16]
EUSTON D R, GRUBER A J, MCNAUGHTON B L. The role of medial prefrontal cortex in memory and decision making[J]. Neuron, 2012, 76(6): 1057-1070. DOI: 10.1016/j.neuron.2012.12.002.
Crossref Google Scholar
[17]
STOPFORD C L, THOMPSON J C, NEARY D, et al. Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia[J]. Cortex, 2012, 48(4): 429-446. DOI: 10.1016/j.cortex.2010.12.002.
Crossref Google Scholar
[18]
JIANG L. Effects of fluoxetine on the neuronal and synaptic pathological changes in the medial prefrontal cortex of the transgenic AD mice[D]. Chongqing: Chongqing Medical University, 2019.
[19]
Institute of Laboratory Animal Resources (US) Committee on Care and Use of Laboratory Animals. Guide for the care and use of Laboratory Animals[M]. 8th ed. Washingto (DC): National Academies Press (US). 2011: No.85-23. DOI: 10.17226/12910.
Crossref
[20]
YUEDE C M, ZIMMERMAN S D, DONG H, et al. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease[J]. Neurobiol Dis, 2009, 35(3): 426-32. DOI: 10.1016/j.nbd.2009.06.002.
Crossref Google Scholar
[21]
HE Q, JIANG L, ZHANG Y, et al. Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD mice[J]. Neurobiol Dis, 2021, 156: 105406. DOI: 10.1016/j.nbd.2021.105406.
Crossref Google Scholar
[22]
VAN DE WERD H J, RAJKOWSKA G, EVERS P, et al. Cytoarchitectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse[J]. Brain Struct Funct, 2010, 214(4): 339-353. DOI: 10.1007/s00429-010-0247-z.
Crossref Google Scholar
[23]
ZHANG L, TANG W, CHAO F L, et al. Four-month treadmill exercise prevents the decline in spatial learning and memory abilities and the loss of spinophilin-immunoreactive puncta in the Hippocampus of APP/PS1 transgenic mice[J]. Neurobiol Dis, 2020, 136: 104723. DOI: 10.1016/j.nbd.2019.104723.
Crossref Google Scholar
[24]
YOUNG K, MORRISON H. Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ[J]. J Vis Exp, 2018(136). DOI: 10.3791/57648.
Crossref Google Scholar
[25]
BAIK S H, KANG S, LEE W, et al. A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer's disease[J]. Cell Metab, 2019, 30(3): 493-507.e6. DOI: 10.1016/j.cmet.2019.06.005.
Crossref Google Scholar
[26]
CUMMINGS J, LEE G, ZHONG K, et al. Alzheimer's disease drug development pipeline: 2021[J]. Alzheimers Dement (N Y), 2021, 7(1): e12179. DOI: 10.1002/trc2.12179.
Crossref Google Scholar
[27]
GODEFROY O, MARTINAUD O, VERNY M, et al. The dysexecutive syndrome of Alzheimer's disease: the GREFEX study[J]. J Alzheimers Dis, 2014, 42(4): 1203-1208. DOI: 10.3233/JAD-140585.
Crossref Google Scholar
[28]
WOODWARD M C, ROWE C C, JONES G, et al. Differentiating the frontal presentation of Alzheimer's disease with FDG-PET[J]. J Alzheimers Dis, 2015, 44(1): 233-242. DOI: 10.3233/JAD-141110.
Crossref Google Scholar
[29]
ZHANG L. The early changes of behavior and amyloid and the white matter in Alzheimer's disease and the effects of exercise on the behavior and the white matter in Alzheimer's disease[D]. Chongqing: Chongqing Medical University, 2014.
[30]
JIANG L. Effects of exercrise on the neurons in the Hippocampus of early APP/PS1 transgenic mouse[D]. Chongqing: Chongqing Medical University, 2015.
[31]
CHAO F L, ZHANG Y, ZHANG L, et al. Fluoxetine promotes hippocampal oligodendrocyte maturation and delays learning and memory decline in APP/PS1 mice[J]. Front Aging Neurosci, 2020, 12: 627362. DOI: 10.3389/fnagi.2020.627362.
Crossref Google Scholar
[32]
KRAEUTER A K, GUEST P C, SARNYAI Z. The Y-maze for assessment of spatial working and reference memory in mice[J]. Methods Mol Biol, 2019, 1916: 105-111. DOI: 10.1007/978-1-4939-8994-2_10.
Crossref Google Scholar
[33]
MILLER E K, LUNDQVIST M, BASTOS A M. Working memory 2.0[J]. Neuron, 2018, 100(2): 463-475. DOI: 10.1016/j.neuron.2018.09.023.
Crossref Google Scholar
[34]
ITTNER A, ITTNER L M. Dendritic tau in Alzheimer's disease[J]. Neuron, 2018, 99(1): 13-27. DOI: 10.1016/j.neuron.2018.06.003.
Crossref Google Scholar
[35]
HICKMAN S, IZZY S, SEN P, et al. Microglia in neurodegeneration[J]. Nat Neurosci, 2018, 21(10): 1359-1369. DOI: 10.1038/s41593-018-0242-x.
Crossref Google Scholar
[36]
VOGELS T, MURGOCI A N, HROMÁDKA T. Intersection of pathological tau and microglia at the synapse[J]. Acta Neuropathol Commun, 2019, 7(1): 109. DOI: 10.1186/s40478-019-0754-y.
Crossref Google Scholar
[37]
SALTER M W, STEVENS B. Microglia emerge as central players in brain disease[J]. Nat Med, 2017, 23(9): 1018-1027. DOI: 10.1038/nm.4397.
Crossref Google Scholar
[38]
CONDELLO C, YUAN P, GRUTZENDLER J. Microglia-mediated neuroprotection, TREM2, and Alzheimer's disease: evidence from optical imaging[J]. Biol Psychiatry, 2018, 83(4): 377-387. DOI: 10.1016/j.biopsych.2017.10.007.
Crossref Google Scholar
[39]
RANSOHOFF R M. A polarizing question: do M1 and M2 microglia exist?[J]. Nat Neurosci, 2016, 19(8): 987-991. DOI: 10.1038/nn.4338.
Crossref Google Scholar
[40]
MATSUMURA A, SUZUKI S, IWAHARA N, et al. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models[J]. J Alzheimers Dis, 2015, 44(2): 409-423. DOI: 10.3233/JAD-141572.
Crossref Google Scholar
[41]
UNGER M S, SCHERNTHANER P, MARSCHALLINGER J, et al. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice[J]. J Neuroinflamm, 2018, 15(1): 274. DOI: 10.1186/s12974-018-1304-4.
Crossref Google Scholar
[42]
HENDRICKX D A E, VAN EDEN C G, SCHUURMAN K G, et al. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology[J]. J Neuroimmunol, 2017, 309: 12-22. DOI: 10.1016/j.jneuroim.2017.04.007.
Crossref Google Scholar
[43]
NAYAK D, ROTH T L, MCGAVERN D B. Microglia development and function[J]. Annu Rev Immunol, 2014, 32: 367-402. DOI: 10.1146/annurev-immunol-032713-120240.
Crossref Google Scholar
[44]
COLONNA M, BUTOVSKY O. Microglia function in the central nervous system during health and neurodegeneration[J]. Annu Rev Immunol, 2017, 35: 441-468. DOI: 10.1146/annurev-immunol-051116-052358.
Crossref Google Scholar
[45]
MANDREKAR S, JIANG Q, LEE C Y, et al. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis[J]. J Neurosci, 2009, 29(13): 4252-62. DOI: 10.1523/JNEUROSCI.5572-08.2009.
Crossref Google Scholar
Journal of Army Medical University
Volume 44 Issue 9,
May 2022
Pages 862-873
DOI: 10.16016/j.2097-0927.202110032
Cite this article:
GUO Y, JIANG L, ZHANG S, et al. Effects of running on medial prefrontal cortex and microglia in APP/PS1 mice. Journal of Army Medical University, 2022, 44(9): 862-873. https://doi.org/10.16016/j.2097-0927.202110032
Metrics & Citations  
Article History
Copyright
Return